204 companies
E8 Partners
Edmond De Rothschild Asset Management
France
Edmond de Rothschild
Etoile Gestion
RF-FP
Eurazeo
Eurazeo Secondary Fund V SLP
France
Europe SAS LMBO
European Capital VIII-35 SC BC
European Capital VIII-36 SC BC
European Capital VIII-38 SC BC
European Capital VIII-39 SC BC
Exane Derivatives
France
Eyevensys S.A.S.
France
FCDE Independent Fund II
France
FURCF
Faurecia/adr
France
NASDAQ
Financiere Agache
Fundlogic Sas
Galion.exe Origin
France
Gaz Electricite Holdings France SAS Total
GNFT
Genfit
genfit is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic, inflammatory, autoimmune and fibrotic diseases, that affect the liver (such as nash - nonalcoholic steatohepatitis) or the bowel (such as the inflammatory bowel disease). genfit is committed to contribute to bringing new medicines to market for patients who lack suitable solutions, and strives to implement mutually beneficial approaches that combine novel drugs and biomarkers.
France
NASDAQ